$149.970
-0.360 (-0.24%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
PVLA Prediction & Forecast by Similar Chart Analysis
Alphio's PVLA stock price prediction model matches the current Palvella Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $146.33 (-2.43%). The 1-week path is $157.09 (+4.75%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Palvella Therapeutics Inc Stock?
Palvella Therapeutics is a good buy right now due to its current price of $149.97, a solid cash position of approximately $251 million, and promising clinical trial results for QTORIN, which could lead to significant revenue growth. The stock has shown a year-to-date change of +49.55% and a one-year change of +184.52%, reflecting strong momentum. However, the main risk is the disappointing Q2 earnings report where the EPS was -$1.52, missing expectations by $0.34, which may affect investor confidence.
PVLA stock price ended at $149.97 on Friday, after losing -0.24%
Palvella Therapeutics Inc (PVLA) last closed at $149.97, losing -0.24%. These facts feed the 1-day and 1-week PVLA price prediction above.
Forecast Drivers
Palvella Therapeutics Inc (PVLA) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches PVLA, ranked by similarity.
Seasonality analysis for PVLA
Historically the probability of a positive August return for PVLA is 100.00%. August offers the highest probability of a positive month at 100.00%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for PVLA
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $21.68 | $26.34 | $29.15 | -82.44% |
| Sep 2026 | $27.00 | $29.87 | $33.64 | -80.08% |
| Oct 2026 | $31.66 | $35.63 | $38.16 | -76.24% |
| Nov 2026 | $32.64 | $32.72 | $33.68 | -78.18% |
| Dec 2026 | $31.06 | $32.44 | $34.32 | -78.37% |
In 2026, Palvella Therapeutics Inc (PVLA) is projected to range from $21.68 to $38.16.
Palvella Therapeutics Inc 2026 monthly forecast
In Aug 2026, Palvella Therapeutics Inc is projected to average $26.34, with a low of $21.68 and high of $29.15.
In Sep 2026, Palvella Therapeutics Inc is projected to average $29.87, with a low of $27.00 and high of $33.64.
In Oct 2026, Palvella Therapeutics Inc is projected to average $35.63, with a low of $31.66 and high of $38.16.
In Nov 2026, Palvella Therapeutics Inc is projected to average $32.72, with a low of $32.64 and high of $33.68.
In Dec 2026, Palvella Therapeutics Inc is projected to average $32.44, with a low of $31.06 and high of $34.32.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.